BCCs can uptake exogenous monounsaturated FA via CD36, but BCCs are highly dependent on the activity of SCD1 in the absence of exogenous monounsaturated FA, and inhibition of SCD1 and CD36 produces a significant anti-tumor synergy in breast cancer.11 This evidence concerns the gene CD36 and breast cancer.